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Exposure to 2,4-difluoroaniline (DFA) was monitored by GC-MS of DFA adducts bound to hemoglobin (Hb). In two studies, involving 20 and 16
workers potentially exposed to low concentrations of DFA, median concentrations of 10 (range 1-83) and 20 (range 4-322) pmole/g Hb were found,
respectively. For better interpretation of these results, the in vivo binding of DFA to Hb was investigated. DFA was administered orally at doses of 0,
0.078, 0.775, 7.75, and 77.5 pmole/kg/day, to 10 male and 10 female Fischer 344 rats for 10 consecutive days (2 rats/sex/dose group). A linear relation
between dose and adduct concentration was observed. At the two lowest doses (0.078 and 0.775 pmole/kg/day) no methemoglobinemia was
observed, but adducts could easily be measured. At these doses, the mean adduct levels were in the same range as found in the human studies.
As yet, no occupational exposure limit for DFA has been established. The German biological tolerance value (BAT-value) for aniline was set at 7.2
nmole/g Hb. This BAT-value is based on the relation between methemoglobinemia and adduct formation. The amount of Hb binding by aniline and
DFA was found to be similar in the rat. Assuming that this is also the case in humans, the BAT-value for aniline may tentatively be used for DFA as
well. In both studies of occupationally exposed workers, the adduct levels were well below this BAT-value. Environ Health Perspect 102(Suppl 6):
27-29 (1994)
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Introduction
2,4-Difluoroaniline (DFA) is produced as a
fine chemical for use in pharmaceutical
industries. The metabolic activation
(Figure 1) of DFA starts with N-oxidation
to the corresponding hydroxylamine which
may be further oxidized in an autocatalytic
cooxidation process with hemoglobin (Hb)
yielding the nitrosoarene and methemoglo-
bin (met-Hb) (1). Exposure to DFA may
be monitored by assessment of the extent
of methemoglobinemia. However, this
method is rather insensitive and only suit-
able to detect very recent exposure. The
nitrosoarene can react with the j-93 cysteine
residue of Hb to a sulfinic acid amide.
After isolation of Hb, the sulfinic acid
amide will yield the original DFA upon
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mild alkaline hydrolysis (2). Determination
of the amount of DFA adduct bound to
Hb is a promising tool for biologic moni-
toring ofpotentially exposed workers (3,4).
We measured the Hb adducts in workers
potentially exposed to DFA by a
modification ofthe gas chromatogra-
phy-mass spectrometry (GC-MS) method
developed by Bryant et al. (5,6). To gain
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Figure 1. Oxidative metabolism of 2,4-difluoroaniline
(A). Ring-oxidation ultimately leads to the sulfate con-
jugate (C) that is excreted into the urine. Via a minor
pathway, the sulfinamide adduct to hemoglobin (B) is
formed. The sulfinamide bond is hydrolyzed under mild
alkaline conditions yielding the original 2,4-difluoroani-
line (A).
more insight into the meaning of the
results, the in vivo binding of DFA to Hb
also was investigated in the rat.
Materials and Methods
Chemicals
DFA was obtained from Shell Chemicals
(Stanlow, UK) and was >99% pure. All
other reagents were purchased commer-
cially and ofthe highest purity.
StudyPopulation
Hb adducts of DFA in human blood were
determined in two studies. In the first
study, blood samples were obtained from
20 male workers potentially exposed to low
DFA concentrations. In the second study,
blood was collected from 16 male workers
involved in the demolition of a plant that
had produced DFA. Blood samples were
collected byvenapuncture from the antecu-
bital vein in sterile 10 ml heparinized vac-
uum tubes and centrifuged. The plasma
and buffy coat were removed and the ery-
throcytes were resuspended three times in
10 ml physiologic saline. The washed ery-
throcytes were resuspended with purified
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water and lysed by subsequent freezing and
thawing. Following sedimentation ofmem-
branes the solution was dialyzed during 48
hr against purified water. The amount of
Hb was assessed spectroscopically using a
Sysmex K-i000 blood analyzer.
After addition of the internal standards
4-chloroaniline (pCA) and d5-aniline
(d5A), aliquots of the dialysate were
hydrolyzed by incubation with 0.1 M
NaOH (final concentration) during 2 hr at
room temperature and protected from light
and analyzed by GC-MS (5,6).
Animal Experiments
SPF Fischer 344 rats were obtained from
Charles River (Manston, UK). The rats
had free access to a commercial diet
(Biosure, Manea, UK) and tap water and
were kept on a 12 hr light and dark cycle.
DFA was dissolved in a 1:1 (v/v) PEG
200:water mixture and administered by
oral gavage (3 ml/kg) to 10 male and 10
female rats for 10 consecutive days. The
doses used were 0, 0.078, 0.775, 7.75 and
77.5 pmole DFA/kg bw/day (2 rats/sex/
dose group). On day 11, the animals were
anesthetized by a lethal dose of sodium
pentobarbitone, and blood samples were
collected by cardiac puncture. Methemo-
globinemia was assessed as reported previ-
ously (7) in a small portion of the blood.
From the remainder, Hb was isolated and
hydrolyzed, after addition of the internal
standards according to Sabbioni and
Neumann (8), and the amount of bound
DFA was determined by GC-MS.
Gas Chromatography-Mass
SpectometryAnalysis
The hydrolysates were prepared for analysis
according to Stillwell et al. (6) with some
minor modifications. Briefly, the DFA was
extracted into dichloromethane (DCM),
derivatized with pentafluoropropionic acid
anhydride (PFPA) without the addition of
trimethylamine. Because the PFPA deriva-
tive of DFA is very volatile, the DCM was
evaporated carefully (the last mililiter by
hand) with a gentle stream of N2 at room
temperature. d5-Aniline was added as a
second internal standard to check whether
losses had occurred during evaporation,
because its PFPA derivative has a volatility
comparable to DFA-PFPA. The residue
was dissolved in ethyl acetate by
sonification and, after centrifugation, the
clear supernatant was analyzed on a
Hewlett Packard 5890 series II gas chro-
matograph equipped with a 5971A mass
selective detector in the electron impact
mode (electron energy fixed at 70 eV; ion
source at 180°C). The GC column was a
60 m x 0.25-mm fused silica capillary
coated with a 0.1-,um film of Durabond-1.
Helium was used as carrier gas at a flow of
1 ml/min. A 1-iil sample was injected using
an HP7673 autosampler in the splitless
mode with an injector temperature of
250°C. The initial oven temperature was
600C for 1 min, followed by a temperature
ramp (20°/min) to 170°C, another ramp
(10°/min) to 300°C, and an isothermal
phase at 300°C of 5 min. The following
ions were monitored with dwell times of
50 msec each: m/z 275 and 128 (DFA),
m/z 244 (d5A), and m/z 273 (pCA).
Calibration graphs were constructed by
plotting the ratio of the integrated peak
areas of the ions of DFA and pCA against
the ratio ofthe amounts DFA and pCA in
a series of Hb samples prepared from con-
trol blood (human or rat) spiked with vary-
ing amounts of DFA and prepared in the
same way as the unknown samples. The
concentration of DFA in the unknown
sample was calculated from this graph and
divided by the concentration of Hb in the
sample.
Results
IndustrialWorkers
In the first study (20 workers), the median
concentration was 10 (range 1-83) pmole
DFA/g Hb. In the second study, a median
adduct concentration of 20 (range 4-322)
pmole/g Hb was found (Figure 2). From
the three workers in the second study with
the highest adduct concentrations (101,
286, and 322 pmole/g Hb) another blood
sample was collected 55 days later. The
concentrations ofHb adducts in these sam-
ples were 39, 46, and 89 pmole DFA/g
Hb, respectively. Assuming first-order
elimination kinetics and that no exposure
occurred between the collection of the
blood samples, half-lives ofthe Hb adducts
of 40, 21, and 30 days, respectively, were
calculated.
RatStudies
In the two lowest dose groups (0.078 and
0.775 pmole/kg/day), no increase in met-
Hb as compared to the controls was
observed (Figure 3). However, adducts
could easily be detected. In the dose groups
of 0.078 pmole/kg/day, mean adduct con-
centrations of 44 (males) and 76 (females)
pmoles/g Hb and in the dose groups of
0.775 pmole/kg/day, mean concentrations
of297 (males) and 435 (females) pmoles/g
Hb were measured. In both male and
female rats, the relationship between dose
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Figure 2. 2,4-Difluoroaniline adducts bound to hemo-
globin in workers exposed to low concentrations of
2,4-difluoroaniline. In study 1 (20 men) the median
concentration was 10 pmoles/g Hb and in study 2 (16
men), 20 pmoles/g Hb.
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Figure 3. Change of methemoglobinemia with dose in
rats orally dosed with 2,4-difluoroaniline for 10 days.
and adduct concentration was linear
(Figure 4). Methemoglobinemia and
adduct formation were higher in the female
animals. The Hb binding index [HBI =
binding (mmole/mole Hb) total dose
(mmole/kg)] (1) was 53 ± 8 for female and
32 ± 4 for male rats.
Discussion
Exposure to DFA may be monitored by
measurement of the met-Hb content in
blood or the urinary concentration of 2-
amino-3,5-difluorophenol sulfate, a major
metabolite of DFA (7). Both methods,
however, reflect only exposure during the
last 24 hr. Hb adducts of arylamines are
thought to be rather stable in vivo and,
consequently, to accumulate in the body.
Hence, the measurement of Hb adducts is
a promising tool for the biologic monitor-
ing of arylamines in the case of intermit-
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Figure 4. Hb adduct formation in rats orally dosed with
2,4-difluoroaniline for 10 days.
tent exposure and chronic exposure to iow
concentrations. We adapted the method
developed by Bryant et al. for 4-amino-
biphenyl (5,6) and applied it to workers
potentially exposed to low concentrations
ofDFA and to rats orally dosed with DFA.
The detection limit of the method was
about 0.5 nM (<5 pmole/g Hb) and Hb
adducts of DFA were readily detectable
both in human and rat blood samples. In
nonexposed persons, no Hb adducts of
DFA could be detected. DFA formed less
Hb adducts in male than in female rats.
The HBIs were 32 ± 4 and 53 ± 8 for male
and female rats, respectively. This agrees
well with the results of Sabbioni (2) who
found a HBI of 32 ± 6 in female Wistar
rats after a single dose of 0.5 mmole
DFA/kg.
It appeared that the adduct concentra-
tions in the human samples corresponded
with the levels found in the rats from the
two lowest dose groups that had been
administered 0.78 and 7.75 pmole DFA/kg
(total dose). As yet, no occupational limit
value has been established for DFA.
Aniline is the only arylamine for which a
biological tolerance value (BAT-value) has
been established. This BAT-value is based
on the relation between met-Hb and
adduct formation (9). It is known that the
formation of met-Hb and Hb adducts are
linked both for DFA and aniline (1,2). In
the rat, the HBIs ofaniline and DFA are of
the same order of magnitude (2).
Assuming that the relative binding ofDFA
and aniline is equal in rats and humans, the
BAT-value for aniline may be applied to
DFA as well. The BAT-value for Hb
adducts of aniline was set at 7.2 nmole/g
Hb (i.e., 100 pg/l whole blood) (9). In
both studies of workers occupationally
exposed to DFA, the adduct levels were
well below this tentative BAT-value.
An important advantage ofthe determi-
nation ofHb adducts instead ofmet-Hb or
urinary metabolites is their longer availabil-
ity in the organism. Theoretically, their life
span could equal the life-span ofthe erythro-
cytes (126 days in men and 65 days in the
rat). Sabbioni (2) found a much shorter
half-life (6.4 days) for DFA in the rat. Even
though the half-lives that were calculated
in this study (21-40 days) may be overesti-
mated because some exposure to DFA
might have occurred to the three persons
between the collections of the two blood
samples, they are much shorter than expected
from the life-span of the erythrocyte. This
suggests either that Hb with DFA bound
to it is more rapidly degraded than native
Hb or that the DFA sulfinamide bond to
the 3-93 cysteine may be hydrolyzed in
vivo. Nevertheless, the stability ofthe adduct
is large enough to enable its detection several
weeks following an exposure to DFA that
would not induce methemoglobinemia.
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